UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Lupus, 2013-01, Vol.22 (1), p.63-72

2013

Volltextzugriff (PDF)

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis

Lupus, 2013-05, Vol.22 (6), p.574-582

2013

Volltextzugriff (PDF)

Systemic lupus erythematosus

BMJ (British Medical Journal), 2006-04, Vol.332 (7546), p.890-894

D'Cruz, David P

International edition, 2006

Volltextzugriff (PDF)

Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids

Lupus, 2012-05, Vol.21 (6), p.649-655

2012

Volltextzugriff (PDF)

Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant

Scandinavian journal of rheumatology, 2015-05, Vol.44 (3), p.211-214

2015

Volltextzugriff (PDF)

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative

Rheumatology (Oxford, England), 2004-11, Vol.43 (11), p.1383-1385

2004

Volltextzugriff (PDF)

Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis

Lupus, 2012-07, Vol.21 (8), p.836-839

2012

Volltextzugriff (PDF)

Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?

Rheumatology (Oxford, England), 2005-04, Vol.44 (4), p.434-442

2005

Volltextzugriff (PDF)

The Euro-Lupus Nephritis Trial: the development of the sequential treatment protocol

Lupus, 2009-09, Vol.18 (10), p.875-877

2009

Volltextzugriff (PDF)

Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise

Rheumatology (Oxford, England), 2003-09, Vol.42 (9), p.1050-1054

2003

Volltextzugriff (PDF)

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1833-1838

2012

Volltextzugriff (PDF)

Systemic lupus erythematosus

The Lancet (British edition), 2007-02, Vol.369 (9561), p.587-596

2007

Volltextzugriff (PDF)

Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies

Journal of rheumatology, 2004-02, Vol.31 (2), p.280

2004

Volltextzugriff (PDF)

The prevalence and associations of fatigue in systemic lupus erythematosus

Rheumatology (Oxford, England), 2000-11, Vol.39 (11), p.1249-1254

2000

Volltextzugriff (PDF)

Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension

Annals of the rheumatic diseases, 2003-10, Vol.62 (10), p.999-1002

2003

Volltextzugriff (PDF)

Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients

Journal of rheumatology, 2005-06, Vol.32 (6), p.1047

2005

Volltextzugriff (PDF)

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

Rheumatology (Oxford, England), 2002-08, Vol.41 (8), p.876-882

2002

Volltextzugriff (PDF)

Renal manifestations of the antiphospholipid syndrome

Lupus, 2005-01, Vol.14 (1), p.45-48

D’Cruz, D P

2005

Volltextzugriff (PDF)

Prevalence of the antiphospholipid syndrome in primary systemic vasculitis

Annals of the rheumatic diseases, 2006-01, Vol.65 (1), p.109-111

2006

Volltextzugriff (PDF)

Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity

Lupus, 2010-09, Vol.19 (10), p.1161-1170

2010

Volltextzugriff (PDF)

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.144-146

2005

Volltextzugriff (PDF)

Mycophenolate mofetil in systemic vasculitis

Lupus, 2005-03, Vol.14 (3_suppl), p.55-57

D'cruz, DP

2005

Volltextzugriff (PDF)

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy

Rheumatology (Oxford, England), 2005-10, Vol.44 (10), p.1317-1321

2005

Volltextzugriff (PDF)

Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study

Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1199-1203

2003

Volltextzugriff (PDF)

Managing antiphospholipid antibodies and antiphospholipid syndrome in children

Haematologica (Roma), 2006-12, Vol.91 (12), p.1674-1680

2006

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(103)
Humans
(84)
Female
(56)
Rheumatology
(52)
Adult
(49)
Biological And Medical Sciences
(47)
Medical Sciences
(44)
Male
(43)
Middle Aged
(35)
Lupus
(19)
Aged
(17)
Immunosuppressive Agents - Therapeutic Use
(16)
Systemic Lupus Erythematosus
(16)
Physical Sciences
(15)
Animals
(14)
Physics
(13)
Treatment Outcome
(13)
Antiphospholipid Antibodies
(11)
Antiphospholipid Syndrome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis

Systemic lupus erythematosus

Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids

Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative

Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis

Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?

The Euro-Lupus Nephritis Trial: the development of the sequential treatment protocol

Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise

Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials

Systemic lupus erythematosus

Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies

The prevalence and associations of fatigue in systemic lupus erythematosus

Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension

Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

Renal manifestations of the antiphospholipid syndrome

Prevalence of the antiphospholipid syndrome in primary systemic vasculitis

Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity

Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data

Mycophenolate mofetil in systemic vasculitis

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy

Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study

Managing antiphospholipid antibodies and antiphospholipid syndrome in children

Suchergebnisse filtern